Global Bio Medical (Shandong) Co., Ltd

The golden age of the pharmaceutical industry has passed, and medical services & devices have become

In the past ten years, driven by the government's increased investment in the healthcare industry, China's healthcare market has experienced a stage of rapid development. As the medical reform continues, the pattern of China's healthcare market will undergo fundamental changes. Zero2IPO Research Center believes that the pharmaceutical industry as a whole will continue to grow rapidly in the future, but the structure will be more optimized. Since the launch of the new medical reform, governments at all levels have increased investment in the construction of medical facilities and equipment updates, and the steady increase in the number of medical services in China has made China's medical device market usher in an era of rapid development. Fundamentally solving the problem of using medicine to raise medicine will be forced to increase the price of medical services. Strong demand and favorable policies will promote the rapid growth of the medical service industry. Mobile medical will drive the development of medical services and related medical device segments.


  The golden age of the pharmaceutical industry has passed, policy dividends are the key


With the aging population, changes in disease spectrum and drug upgrades continuing, the medium- and long-term growth trend of the biopharmaceutical industry remains unchanged. The impact is more profound; although the country’s regulatory policies for the pharmaceutical industry are complex and changeable, the industry trends behind the policy changes are still relatively clear, such as strengthening the rationality of drug use, encouraging the import substitution of high generic drugs, and prioritizing clinical drugs in urgent need of generic drugs. Comment on optimizing the competitive landscape of the industry.


   Good policy & market demand, medical devices enter the fast lane of development


  Since the launch of the new medical reform in 2009, governments at all levels have increased investment in the construction of medical facilities and equipment renewal. In addition to the steady increase in the number of medical services in China, the Chinese medical device market has ushered in an era of rapid development. With the improvement of relevant laws and regulations, the policy guidance of the Chinese government in the medical device industry director has become clearer, that is, gradually improving regulatory efficiency, encouraging innovation, especially domestic key innovation, and strengthening quality and safety.


  Medical service is the focus of medical reform, mobile medical will drive the development of related industries


  The greater benefit in the medical reform process is privatization (that is, the reform of public hospitals), and medical services will continue to benefit from the institutional dividends brought about by industry reforms during this longer period. At present, medical services currently account for a relatively low percentage in the medical and health industry as a whole, and there is basically no policy resistance. The policy environment is superior to the pharmaceutical industry, and the future space is huge. Under the high growth trend of the mobile medical market, the evolution from horizontal applications to vertical solutions to open up the value chain of mobile medical services will become the industry's development direction.


C-606, China Railway Construction Building, West Aoti Road, Lixia District, Jinan City, Shandong Province

+86-0531 8118 4978
+86 16653132123

gbmbio2020@gmail.com
10:00-23:00